Total Payments
$1,531
2024 Payments
$824.36
Companies
15
Transactions
45
Medicare Patients
670
Medicare Billing
$97,132
Payment Breakdown by Category
Food & Beverage$1,531 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,531 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Inspire Medical Systems, Inc. | $567.26 | 2 | $0 (2024) |
| Allergan, Inc. | $257.86 | 15 | $0 (2020) |
| ZOLL Respicardia, Inc. | $177.99 | 1 | $0 (2024) |
| ABBVIE INC. | $126.45 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $90.84 | 5 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $83.53 | 4 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $35.22 | 2 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $31.84 | 2 | $0 (2019) |
| PFIZER INC. | $29.22 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $26.30 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $824.36 | 6 | Inspire Medical Systems, Inc. ($567.26) |
| 2023 | $20.35 | 1 | ABBVIE INC. ($20.35) |
| 2022 | $22.04 | 1 | Abbott Laboratories ($22.04) |
| 2021 | $26.99 | 2 | AbbVie Inc. ($26.99) |
| 2020 | $130.98 | 7 | Allergan, Inc. ($35.79) |
| 2019 | $198.34 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($59.42) |
| 2018 | $96.06 | 5 | Allergan Inc. ($56.25) |
| 2017 | $211.49 | 12 | Allergan Inc. ($113.24) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/26/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/11/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE, TEFLARO | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/04/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $177.99 | General |
| Category: Respiratory | ||||||
| 02/15/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $429.65 | General |
| Category: NEUROLOGY | ||||||
| 02/06/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $137.61 | General |
| Category: NEUROLOGY | ||||||
| 01/11/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/12/2022 | Abbott Laboratories | 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Heart Failure | ||||||
| 05/11/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/01/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/29/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $18.71 | General |
| Category: Oncology | ||||||
| 12/15/2020 | Servier Pharmaceuticals LLC | ASPARLAS (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: ONCOLOGY | ||||||
| 06/09/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/12/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/27/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: RESPIRATORY | ||||||
| 01/16/2020 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/13/2020 | Allergan, Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/03/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.03 | General |
| Category: Cardiovascular | ||||||
| 11/21/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/25/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2019 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/10/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 52 | 66 | $47,900 | $5,251 |
| 2022 | 3 | 52 | 92 | $56,637 | $6,705 |
| 2021 | 4 | 129 | 214 | $164,484 | $18,435 |
| 2020 | 4 | 437 | 653 | $574,680 | $66,741 |
Total Patients
670
Total Services
1,025
Medicare Billing
$97,132
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 46 | $21,032 | $2,631 | 12.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $26,868 | $2,620 | 9.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 47 | $33,416 | $3,872 | 11.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 30 | $13,075 | $1,649 | 12.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 15 | 15 | $10,146 | $1,184 | 11.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 63 | 136 | $100,790 | $11,431 | 11.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 18 | $25,911 | $2,699 | 10.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 28 | 28 | $21,384 | $2,435 | 11.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 32 | $16,400 | $1,871 | 11.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 184 | 377 | $279,395 | $32,459 | 11.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 140 | 144 | $207,288 | $24,038 | 11.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 80 | 81 | $61,861 | $7,214 | 11.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 33 | 51 | $26,137 | $3,030 | 11.6% |
About Dr. Abdullah Khalid, MD
Dr. Abdullah Khalid, MD is a Pulmonary Disease healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2013. The National Provider Identifier (NPI) number assigned to this provider is 1811239981.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abdullah Khalid, MD has received a total of $1,531 in payments from pharmaceutical and medical device companies, with $824.36 received in 2024. These payments were reported across 45 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,531).
As a Medicare-enrolled provider, Khalid has provided services to 670 Medicare beneficiaries, totaling 1,025 services with total Medicare billing of $97,132. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine, Critical Care Medicine
- Location Portland, OR
- Active Since 03/26/2013
- Last Updated 10/11/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1811239981
Products in Payments
- INSPIRE (Device) $567.26
- remede System (Device) $177.99
- TEFLARO (Drug) $145.13
- AVYCAZ (Drug) $141.32
- DALVANCE (Drug) $97.86
- XARELTO (Drug) $90.84
- ELIQUIS (Drug) $61.06
- STIOLTO RESPIMAT (Drug) $60.17
- BRILINTA (Drug) $26.30
- ENTRESTO (Drug) $24.34
- SPIRIVA RESPIMAT (Drug) $23.36
- 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) $22.04
- ASPARLAS (Drug) $22.01
- SAMSCA (Drug) $21.49
- Lenvima (Drug) $18.71
- ZERBAXA (Drug) $17.00
- ABILIFY MAINTENA (Drug) $13.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Portland
Jordan Fein, M.d, M.D
Pulmonary Disease — Payments: $69,409
Pulmonary Disease $69,409
Granthem Farr, Do, DO
Pulmonary Disease — Payments: $66,353
Pulmonary Disease $66,353
Melvin Morganroth, Md, MD
Pulmonary Disease — Payments: $23,131
Pulmonary Disease $23,131
Dr. Bishoy Zakhary, Md, MD
Pulmonary Disease — Payments: $10,967
Pulmonary Disease $10,967
Rick Balestra, M.d, M.D
Pulmonary Disease — Payments: $9,856
Pulmonary Disease $9,856
Vikram Sahni, M.d, M.D
Pulmonary Disease — Payments: $4,784
Pulmonary Disease $4,784